Login / Signup
Ruemu Ejedafeta Birhiray
(Ruemu Birhiray)
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 5
2025
2016
Top Topics
2025
2016
Acute Myeloid Leukemia
2025
2016
Clinical Trial
2025
2016
Nk Cells
2025
2016
Low Dose
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
Blood advances
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Joseph C Lownik
,
Jonathan Boiarsky
,
Ruemu Ejedafeta Birhiray
,
Akil A Merchant
,
Grzegorz S Nowakowski
Sequencing of Anti-CD19 Therapies in the Management of Diffuse Large B-Cell Lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (14) (2024)
Joseph C Lownik
,
Jonathan Boiarsky
,
Ruemu Ejedafeta Birhiray
,
Akil A Merchant
,
Grzegorz S Nowakowski
Sequencing of Anti-CD19 Therapies in the Management of Diffuse Large B-Cell Lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (14) (2024)
Joseph C Lownik
,
Jonathan Boiarsky
,
Ruemu Ejedafeta Birhiray
,
Akil A Merchant
,
Grzegorz S Nowakowski
Sequencing of anti-CD19 therapies in the management of diffuse large B-cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Joseph C Lownik
,
Jonathan Boiarsky
,
Ruemu Ejedafeta Birhiray
,
Akil A Merchant
,
Grzegorz S Nowakowski
Sequencing of Anti-CD19 Therapies in the Management of Diffuse Large B-Cell Lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (14) (2024)
Maya Nicole Birhiray
,
Ruemu Ejedafeta Birhiray
Practical strategies for creating diversity, equity, inclusion, and access in cancer clinical research: DRIVE.
Blood advances
(2022)